Certain coagulation markers, such as D‐dimer, thrombin–antithrombin complex (TAT), tissue plasminogen activator/plasminogen activator inhibitor‐1 complex (t‐PAIC), thrombomodulin (TM), and plasmin‐antiplasmin complex (PIC), have been extensively studied for their predictive value in cancer‐associated VTE [21]. The gene discussed is THBD; the disease is cancer.